Sign up

Deerfield Management Company, L.P.

$9.6B assets · 82 holdings · Q2 2026 · Filed 14 AUG 2026

About Deerfield Management Company, L.P.’s 13F portfolio

Deerfield Management Company, L.P. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Deerfield Management Company, L.P. reported $9.6B across 82 US-listed positions (). Its largest position is NUVALENT INC (NUVL) at 22% of the reported book, and its ten biggest holdings make up 53% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$9.6B
Assets (13F)
#509
of 8,845 by size
82
Holdings
53%
Top-10 weight
27
Buys
25
Sells
Top holdings · Q2 2026
82 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: NUVL
NUVALENT INC
$123.96
0.00%
22%
17.2M$2.1B
2
NYSE: BKD
BROOKDALE SR LIVING INC
$8.69
+1.16%
6.1%
306.9M$585.7M
3
NASDAQ: RVMD
REVOLUTION MEDICINES INC
$159.43
−0.24%
4.7%
2.4M$448.0M
4
NASDAQ: PRAX
PRAXIS PRECISION MEDICINES I
$310.90
+1.87%
3.4%
963K$322.5M
5
NASDAQ: VTRS
VIATRIS INC
$19.88
−1.97%
3.3%
20.2M$320.9M
6
NYSE: CNC
CENTENE CORP DEL
$65.58
−2.77%
3.3%
4.9M$314.6M
7
—
REVOLUTION MEDICINES INC
—
—
2.6%
200.0M$251.7M
8
NASDAQ: UTHR
UNITED THERAPEUTICS CORP DEL
$559.10
−3.16%
2.6%
457K$247.6M
9
NASDAQ: ARWR
ARROWHEAD PHARMACEUTICALS IN
$43.65
+1.25%
2.5%
200.0M$240.5M
10
NASDAQ: LEGN
LEGEND BIOTECH CORP
$16.10
−0.92%
2.5%
8.1M$235.0M
11
NASDAQ: COGT
COGENT BIOSCIENCES INC
$27.74
−0.25%
2.0%
5.0M$193.7M
12
NASDAQ: GMAB
GENMAB A/S
$51.35
+0.75%
2.0%
6.9M$188.6M
13
NYSE: BKD
BROOKDALE SR LIVING INC
$8.69
+1.16%
2.0%
11.6M$187.2M
14
NASDAQ: VERA
VERA THERAPEUTICS INC
$26.75
+4.57%
1.8%
3.9M$168.1M
15
NASDAQ: IONS
IONIS PHARMACEUTICALS INC
$27.22
−0.62%
1.6%
2.0M$157.0M
16
NASDAQ: CELC
CELCUITY INC
$56.31
+1.28%
1.6%
1.5M$151.8M
17
NASDAQ: BCRX
BIOCRYST PHARMACEUTICALS INC
$7.32
+0.27%
1.6%
15.1M$151.0M
18
NASDAQ: NAMS
NEWAMSTERDAM PHARMA COMPANY
$19.51
−1.17%
1.5%
4.3M$144.5M
19
NASDAQ: ACHC
ACADIA HEALTHCARE COMPANY IN
$34.47
−8.30%
1.4%
4.5M$133.5M
20
NASDAQ: TNGX
TANGO THERAPEUTICS INC
$22.71
+3.75%
1.4%
4.2M$131.0M
21
NASDAQ: AHCO
ADAPTHEALTH CORP
$7.25
−1.63%
1.2%
11.5M$119.6M
22
NASDAQ: PHVS
PHARVARIS N V
$31.66
+0.35%
1.2%
3.4M$116.7M
23
NASDAQ: CELC
CELCUITY INC
$56.31
+1.28%
1.2%
100.0M$113.8M
24
NASDAQ: ARWR
ARROWHEAD PHARMACEUTICALS IN
$43.65
+1.25%
1.2%
1.4M$113.2M
25
NASDAQ: DNTH
DIANTHUS THERAPEUTICS INC
$84.83
+1.01%
1.1%
1.1M$109.7M

Showing 1–25 of 82 positions on this page reported in this 13F.

Sector allocation
  • Healthcare96%
Recent activity · vs 2026-03-31
Bought27
  • AddedRVMDREVOLUTION MEDICINES INC+4.1%$448.0M
  • New—REVOLUTION MEDICINES INC—$251.7M
  • AddedLEGNLEGEND BIOTECH CORP+5.9%$235.0M
  • AddedGMABGENMAB A/S+179%$188.6M
  • AddedVERAVERA THERAPEUTICS INC+5.2%$168.1M
  • AddedBCRXBIOCRYST PHARMACEUTICALS INC+0.4%$151.0M
  • AddedTNGXTANGO THERAPEUTICS INC+1.1%$131.0M
  • AddedPHVSPHARVARIS N V+8.0%$116.7M
  • NewCELCCELCUITY INC—$113.8M
  • AddedDNTHDIANTHUS THERAPEUTICS INC+10.3%$109.7M
Sold25
  • ReducedCNCCENTENE CORP DEL−17.2%$314.6M
  • ReducedCOGTCOGENT BIOSCIENCES INC−44.6%$193.7M
  • ReducedCELCCELCUITY INC−15.3%$151.8M
  • ReducedARWRARROWHEAD PHARMACEUTICALS IN−11.7%$113.2M
  • ReducedLNTHLANTHEUS HLDGS INC−9.1%$83.5M
  • ReducedINDVINDIVIOR PHARMACEUTICALS INC−46.8%$67.7M
  • ReducedINSPINSPIRE MED SYS INC−52.0%$57.9M
  • ReducedCDNACAREDX INC−8.8%$56.9M
  • ReducedCERTCERTARA INC−3.8%$49.2M
  • ReducedSIONSIONNA THERAPEUTICS INC−29.8%$30.0M

Reading Deerfield Management Company, L.P.’s 13F portfolio

Deerfield Management Company, L.P.’s $9.6B 13F book is spread across 82 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 53%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are NUVL, BKD, RVMD, PRAX and VTRS, led by NUVALENT INC (NUVL) at 22% of the portfolio. The heaviest sector exposure is Healthcare (96%).

What Deerfield Management Company, L.P. changed last quarter

Between 2026-03-31 and Q2 2026, Deerfield Management Company, L.P. was roughly balanced between buying and selling: it opened 13 new positions and added to 14 more, while trimming 12 and closing 13 outright. Against a 82-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was REVOLUTION MEDICINES INC (RVMD), and its biggest reduction was CENTENE CORP DEL (CNC).

What a 13F does and doesn’t reveal

A 13F captures only Deerfield Management Company, L.P.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Deerfield Management Company, L.P. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Deerfield Management Company, L.P.'s profile on this page is built directly from those filings.

How current is the 13F data on Deerfield Management Company, L.P.'s page?

It reflects Deerfield Management Company, L.P.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Deerfield Management Company, L.P. files its next quarterly report, this page refreshes automatically.

Can I see Deerfield Management Company, L.P.'s complete list of holdings?

This page highlights Deerfield Management Company, L.P.'s largest positions rather than all 82 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Deerfield Management Company, L.P.'s filings.

Does a 13F show everything Deerfield Management Company, L.P. owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Deerfield Management Company, L.P.'s book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Deerfield Management Company, L.P. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.